Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Franz Rödel, Daniel Martin, Christina Helmke, Panagiotis Balermpas, Emmanouil Fokas, Ulrike Wieland, Margret Rave-Fränk, Julia Kitz, Yves Matthess, Monika Raab, Klaus Strebhardt, Claus Rödel
Published Jul 23, 2016 · Vol. 7, No. 33 · pp. 53339-53349
Eric W. Prince, Ilango Balakrishnan, Monil Shah, Jean M. Mulcahy Levy, Andrea M. Griesinger, Irina Alimova, Peter S. Harris, Diane K. Birks, Andrew M. Donson, Nathan Davidson, Marc Remke, Michael D. Taylor, Michael H. Handler, Nicholas K. Foreman, Sujatha Venkataraman, Rajeev Vibhakar
Published Jul 19, 2016 · Vol. 7, No. 33 · pp. 53881-53894
Anna Babayan, Malik Alawi, Michael Gormley, Volkmar Müller, Harriet Wikman, Ryan P. McMullin, Denis A. Smirnov, Weimin Li, Maria Geffken, Klaus Pantel, Simon A. Joosse
Published Jul 19, 2016 · Vol. 8, No. 34 · pp. 56066-56080